company background image
300357 logo

Zhejiang Wolwo Bio-Pharmaceutical XSEC:300357 Stock Report

Last Price

CN¥21.51

Market Cap

CN¥11.3b

7D

-0.6%

1Y

-20.7%

Updated

24 Dec, 2024

Data

Company Financials +

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

XSEC:300357 Stock Report

Market Cap: CN¥11.3b

300357 Stock Overview

A biopharmaceutical company, engages in the research, development, production, and sale of pharmaceutical products for the diagnosis and treatment of allergic diseases in China and internationally. More details

300357 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth3/6
Past Performance5/6
Financial Health5/6
Dividends4/6

My Notes

Capture your thoughts, links and company narrative

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Zhejiang Wolwo Bio-Pharmaceutical
Historical stock prices
Current Share PriceCN¥21.51
52 Week HighCN¥29.21
52 Week LowCN¥16.32
Beta0.72
1 Month Change-3.02%
3 Month Change23.41%
1 Year Change-20.69%
3 Year Change-60.68%
5 Year Change-51.28%
Change since IPO-7.44%

Recent News & Updates

Recent updates

Shareholder Returns

300357CN PharmaceuticalsCN Market
7D-0.6%-1.0%0.4%
1Y-20.7%-3.0%12.3%

Return vs Industry: 300357 underperformed the CN Pharmaceuticals industry which returned -4.4% over the past year.

Return vs Market: 300357 underperformed the CN Market which returned 9.8% over the past year.

Price Volatility

Is 300357's price volatile compared to industry and market?
300357 volatility
300357 Average Weekly Movement10.7%
Pharmaceuticals Industry Average Movement7.4%
Market Average Movement8.8%
10% most volatile stocks in CN Market13.0%
10% least volatile stocks in CN Market5.8%

Stable Share Price: 300357 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 300357's weekly volatility (11%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20021,709Gengxi Huwww.wolwobiotech.com

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceutical products for the diagnosis and treatment of allergic diseases in China and internationally. The company offers Changdi, a farinae farinae drops; Changhao, an artemisia annua pollen allergen sublingual drops; Changdian, a dust mite skin prick diagnostic kits; and Changdian II, a house dust mite skin pricking diagnostic kits. It also involved in the research and development of stem cells and medical artificial intelligence solutions.

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Fundamentals Summary

How do Zhejiang Wolwo Bio-Pharmaceutical's earnings and revenue compare to its market cap?
300357 fundamental statistics
Market capCN¥11.26b
Earnings (TTM)CN¥312.29m
Revenue (TTM)CN¥904.64m

36.1x

P/E Ratio

12.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300357 income statement (TTM)
RevenueCN¥904.64m
Cost of RevenueCN¥43.86m
Gross ProfitCN¥860.78m
Other ExpensesCN¥548.49m
EarningsCN¥312.29m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.60
Gross Margin95.15%
Net Profit Margin34.52%
Debt/Equity Ratio1.5%

How did 300357 perform over the long term?

See historical performance and comparison

Dividends

0.9%

Current Dividend Yield

31%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 11:29
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. is covered by 9 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kai WangCitic Securities Co., Ltd.
Xiao Wei LinEverbright Securities Co. Ltd.
Yaming LiuFounder Securities Co., Ltd.